1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease : protocol for a systematic review and individual participant data meta-analysis
Eusebi, Paolo ; Hansson, Oskar LU
; Paciotti, Silvia
; Orso, Massimiliano
; Chiasserini, Davide
; Calabresi, Paolo
; Blennow, Kaj
LU
and Parnetti, Lucilla
(2017)
In BMJ Open
7(11).
p.018177-018177
Mark
- Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease
- 2016
-
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis
Parnetti, Lucilla ; Cicognola, Claudia LU
; Eusebi, Paolo
and Chiasserini, Davide
(2016)
In Biomarkers in Medicine
10(1).
p.35-49
Mark
-
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF
Cicognola, Claudia LU
; Chiasserini, Davide
; Eusebi, Paolo
; Andreasson, Ulf
; Vanderstichele, Hugo
; Zetterberg, Henrik
LU
; Parnetti, Lucilla
and Blennow, Kaj
LU
(2016)
In Molecular Neurodegeneration
11(1).
Mark
- Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
- 2015
-
Preanalytical confounding factors in the analysis of cerebrospinal fluid biomarkers for Alzheimer's disease : The issue of diurnal variation
Cicognola, Claudia LU
; Chiasserini, Davide
and Parnetti, Lucilla
(2015)
In Frontiers in Neurology
6(JUN).
Mark